Retatrutide Canada is available through Vancouver Island Peptides — synthesized domestically at our boutique Vancouver, BC lab partner. We do not import. Every vial of Retatrutide in Canada we supply is produced right here in British Columbia, ensuring consistent purity, full traceability, and no overseas seizure risk.
Available in 10mg and 20mg lyophilized powder vials. Ships Canada-wide in plain, discreet packaging.
Retatrutide (also known as LY3437943) is a next-generation synthetic peptide classified as a triple receptor agonist. Unlike Semaglutide (GLP-1 only) or Tirzepatide (GLP-1 + GIP), Retatrutide simultaneously activates three hormone receptors:
This triple mechanism is what distinguishes Retatrutide as the most advanced compound in its class for metabolic research. Early phase clinical trials have demonstrated exceptional outcomes in weight management and metabolic optimization research.
The Canadian research peptide landscape has evolved rapidly. Here is how the three major GLP-1 compounds compare:
| Compound | Receptor Targets |
| Semaglutide (Ozempic) | GLP-1 only |
| Tirzepatide (Mounjaro) | GLP-1 + GIP |
| Retatrutide | GLP-1 + GIP + Glucagon |
For researchers comparing Retatrutide Canada against other peptides, the triple receptor coverage offers the broadest metabolic research profile currently available as a domestic peptide in Canada.
| Product Name | Retatrutide (LY3437943) |
| Format | Lyophilized Powder |
| Available Sizes | 10mg, 20mg |
| Purity | >99% (HPLC verified) |
| Storage | −20°C, away from light |
| Origin | Domestic — Vancouver, BC, Canada |
| Shipping | Canada-wide, discreet packaging |
| Payment | Bitcoin (BTC) |
As a trusted source of domestic peptides in Canada, we offer something most suppliers cannot: actual Canadian synthesis. Our Retatrutide is not imported from overseas and rebranded — it is produced at our Vancouver lab partner under strict quality controls. No import risk. No unknown sourcing. Pacific Northwest Purity.
View Retatrutide on the Store